INTRODUCTION
============

The use of endovascular grafts for the treatment of aortic aneurysms has increased significantly. Bacterial infections of these grafts, either in the perioperative period or later, are a feared complication with possibly fatal results. Although there are no clear guidelines for the management of these infections, antibiotic treatment is less accepted and the surgical approach (i.e. removal of the infected graft) is commonly adopted. We describe here a rare case of successful long-term antibiotic treatment of a recurrent graft infection due to multiple infectious agents.

CLINICAL CASE
=============

An 82-year-old man, whose past medical history includes smoking, hypertension, ischaemic heart disease, dyslipidaemia, benign prostatic hyperplasia, cholecystectomy and an abdominal aortic aneurysm treated by graft insertion 10 years previously, was admitted to our internal medicine department with recurrent episodes of general weakness, chills and high fever. Blood cultures were consistently positive for *Escherichia coli*. The patient was treated with IV antibiotics with resolution of fever and symptoms. Between the febrile episodes related to E. coli bacteraemia, the patient was asymptomatic and repeated blood cultures were negative. An extensive diagnostic and imaging work-up including renal US, CT urography, cystoscopy, colonoscopy, echocardiography and magnetic resonance cholangiopancreatography (MRCP) did not reveal the source of the recurrent infection.

However, CT angiography of the abdominal aorta demonstrated signs of aortitis in the area of the graft adjacent to the third part of the duodenum with a suspected aorto-enteric fistula. A PET-CT scan detected pathological uptake and wall thickening of the aortic graft consistent with infectious aortitis. The patient was offered surgical removal of the infected graft. He declined due to the substantial perioperative risk, so chronic daily maintenance treatment with intravenous ceftriaxone was administered via a permanent central catheter. More than 20 months have passed since diagnosis. During this period, the patient was admitted four more times with recurrent episodes of bacteraemia due to ESBL-positive *E. coli* and *Candida albicans* that were successfully treated with ertapenem and fluconazole, respectively. The patient continues to feel well under daily antibiotic therapy and to decline surgical treatment.

DISCUSSION
==========

The incidence and prevalence of bacterial infections of endovascular grafts are significant, reaching 3% in different reviews^\[[@b1-913-1-5703-1-10-20180625]\]^. These numbers are expected to grow in view of the preferential employment of these grafts to treat a variety of vascular pathologies^\[[@b2-913-1-5703-1-10-20180625]\]^.

Graft infections are associated with a very high rate of mortality, which reaches 56.5%^\[[@b3-913-1-5703-1-10-20180625]\]^. The most common infectious organisms are Gram-positive cocci, especially *Staphylococcus aureus* and *Staphylococcus epidermidis*, and to a much lesser extent, Gram-negative bacilli and *E. coli* infection, which is particularly rare^\[[@b1-913-1-5703-1-10-20180625]\]^. The optimal management of prosthetic graft infection is unclear, but the common default approach is complete removal of the infected graft^\[[@b3-913-1-5703-1-10-20180625]\]^. Some patients with very high perioperative risk may undergo full or partial graft preservation with instillation or irrigation of local antibiotics or continuous intravenous antibiotic treatment^\[[@b1-913-1-5703-1-10-20180625],[@b4-913-1-5703-1-10-20180625]\]^, although there are no clear guidelines regarding conservative non-surgical treatment of these infections and only a handful of reports describe short-term conservative antibiotic treatment of endovascular graft infections^\[[@b5-913-1-5703-1-10-20180625]\]^. As the use of endovascular stent grafting is becoming widespread, there is a growing need to deal with the complications of this procedure, namely infections. This is particularly true as patients undergoing this treatment are older and have a greater burden of chronic diseases^\[[@b2-913-1-5703-1-10-20180625]\]^. Therefore, many patients are not candidates for the preferred surgical treatment or refuse it altogether, like our patient. Thus, the long-term clinical stability achieved in our patient with chronic ambulatory maintenance antibiotic therapy provides a practical and efficient therapeutic modality which may be adopted in a growing number of similar patients.

Future studies comparing surgical and conservative management of infected endovascular grafts are needed to determine which of these approaches is best in a particular patient.
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